Results 21 to 30 of about 205,719 (255)

A polymorphism in a let-7 microRNA binding site of KRAS in women with endometriosis. [PDF]

open access: yes, 2012
Endometriosis is found in 5-15% of women of reproductive age and is more frequent in relatives of women with the disease. Activation of KRAS results in de novo endometriosis in mice, however, activating KRAS mutations have not been identified in women ...
Chan, Elcie   +8 more
core   +1 more source

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy [PDF]

open access: yesMolecular Cancer, 2019
Lung cancer patients with KRAS mutation(s) have a poor prognosis due in part to the development of resistance to currently available therapeutic interventions. Development of a new class of anticancer agents that directly targets KRAS may provide a more attractive option for the treatment of KRAS-mutant lung cancer.Here we identified a small molecule ...
Ke Xu   +8 more
openaire   +3 more sources

Nesting of Eurasian Crag Martin (Ptyonoprogne rupestris) in the Malá Fatra Mts. in Slovakia

open access: yesTichodroma, 2022
We detected occurrence and nesting of Eurasian Craig Martin (Ptyonoprogne rupestris) for the first time in Slovakia. One nesting pair with four juveniles was detected during the 2022 nesting season in the Malá Fatra mountains.
Štefan Matis   +2 more
doaj   +1 more source

Molecular genetic testing in colon cancer: clinical aspects

open access: yesAlʹmanah Kliničeskoj Mediciny, 2022
Molecular genetic diagnostics is an essential element to plan for management of colorectal cancer (CRC) patients. The choice of systemic treatment for CRC is impossible without molecular testing of the tumor.
Aleksandr S. Martianov   +3 more
doaj   +1 more source

RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis [PDF]

open access: yes, 2016
Tumor suppression that is mediated by oncogene-induced senescence (OIS) is considered to function as a safeguard during development of pancreatic ductal adenocarcinoma (PDAC). However, the mechanisms that regulate OIS in PDAC are poorly understood. Here,
Algül, Hana   +17 more
core   +1 more source

The Religious Policy of Sigismund I and Sigismund II Augustus in the Reformation Period: status quaestionis

open access: yesActa Historica Universitatis Klaipedensis, 2014
The article examines the role of the last Jagiellonian monarchs, Sigismund I (1506-1548) and his son Sigismund II Augustus (1548-1572), in promoting and securing religious peace in the multi-confessional society of the 16th-century Rzeczpospolita.
Paweł Kras
doaj   +1 more source

Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors

open access: yesOncoImmunology, 2021
T-cell receptor (TCR) redirected T cells are considered as the next generation of care for the treatment of numerous solid tumors. KRAS mutations are driver neoantigens that are expressed in over 25% of all cancers and are thus regarded as ideal targets ...
Pierre Dillard   +7 more
doaj   +1 more source

Outcomes of patients with advanced cancer and KRAS mutations in phase I clinical trials. [PDF]

open access: yes, 2014
BackgroundKRAS mutation is common in human cancer. We assessed the clinical factors, including type of KRAS mutation and treatment, of patients with advanced cancer and tumor KRAS mutations and their association with treatment outcomes.MethodsPatients ...
Aldape, Kenneth   +15 more
core   +2 more sources

Biomarker series: KRAS- A narrative review

open access: yesCancer Research, Statistics, and Treatment, 2021
Non-small cell lung cancer (NSCLC) has emerged as the poster child of molecular medicine. Kirsten rat sarcoma (KRAS)-mutated NSCLC is a common yet heterogeneous entity with distinct clinical and prognostic characteristics.
Ullas Batra, Shrinidhi Nathany
doaj   +1 more source

Home - About - Disclaimer - Privacy